Adaptive Biotechnologies Corp (ADPT)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.70B
Last updated: Nov 17, 2026 at 11:04 AM ET
Adaptive Biotechnologies Corp (ADPT) Competitors
The companies most similar to Adaptive Biotechnologies are CareDx (CDNA), GRAIL, LLC (GRAL) and Sotera Health (SHC). By market cap, Adaptive Biotechnologies ranks 7th of the 13 companies on this page; Revvity (RVTY) is the largest at $17.24B. The median P/E of the 9 companies with a P/E is 31.8x.
Peer Comparison
ADPT's revenue growth of -10.7% is below the peer median of 13.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies (ADPT) | $4.70B | N/A | 15.0x | -23.7% | N/A | -10.7% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| Sotera Health Co (SHC) | $4.74B | 17.1x | 3.8x | 14.1% | 9.0% | 4.4% | 0.00% |
| Veracyte Inc (VCYT) | $1.96B | 13.3x | 3.3x | 21.8% | 8.2% | 15.1% | 0.00% |
| RadNet Inc (RDNT) | $6.02B | 141.5x | 2.5x | -0.9% | 2.7% | 22.1% | 0.00% |
| NeoGenomics Inc (NEO) | $2.07B | 228.9x | 2.6x | -4.1% | -2.5% | 11.4% | 0.00% |
| Personalis Inc (PSNL) | $1.70B | N/A | 20.9x | -147.7% | N/A | 76.6% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Qiagen NV (QGEN) | $10.30B | 20.5x | 4.9x | 18.2% | 8.2% | 2.9% | 0.70% |
| Charles River Laboratories (CRL) | $16.19B | 31.8x | 4.0x | 1.0% | 0.1% | -2.2% | 0.00% |
| Castle Biosciences Inc (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| Revvity Inc. (RVTY) | $17.24B | 26.8x | 5.6x | 8.6% | 3.4% | 4.3% | 0.19% |
| Peer median | $4.42B | 31.8x | 3.9x | 0.5% | 3.0% | 13.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Adaptive Biotechnologies, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Diagnostics & Research; the other one is in Biotechnology.
| Company | About | Peers |
|---|---|---|
| CareDx Inc (CDNA)Diagnostics & Research | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| GRAIL, LLC (GRAL)Diagnostics & Research | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| Sotera Health Co (SHC)Diagnostics & Research | Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical... | SHC competitors |
| Veracyte Inc (VCYT)Diagnostics & Research | Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California. | VCYT competitors |
| RadNet Inc (RDNT)Diagnostics & Research | RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California. | RDNT competitors |
| NeoGenomics Inc (NEO)Diagnostics & Research | NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. | NEO competitors |
| Personalis Inc (PSNL)Diagnostics & Research | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. | PSNL competitors |
| Legend Biotech Corp (LEGN)Biotechnology | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Qiagen NV (QGEN)Diagnostics & Research | QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. | QGEN competitors |
| Charles River Laboratories (CRL)Diagnostics & Research | Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory... | CRL competitors |
| Castle Biosciences Inc (CSTL)Diagnostics & Research | Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests... | CSTL competitors |
| Revvity Inc. (RVTY)Diagnostics & Research | Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. | RVTY competitors |
Frequently Asked Questions About ADPT
Who are Adaptive Biotechnologies' main competitors?
The companies most similar to Adaptive Biotechnologies include CareDx (CDNA), GRAIL, LLC (GRAL), Sotera Health (SHC), Veracyte (VCYT) and RadNet (RDNT), listed from the closest match.
Who is Adaptive Biotechnologies' biggest competitor?
Revvity (RVTY) is the largest of the similar companies at $17.24B; CareDx (CDNA) is the closest match by business profile, size, sector and industry.
How does ADPT stock compare with its competitors?
ADPT's P/S is 15.0x against a peer median of 3.9x; its net margin is -23.7% against a peer median of 0.5%.
Which of Adaptive Biotechnologies' competitors pays a higher dividend?
Adaptive Biotechnologies pays no dividend. Qiagen NV (QGEN) and Revvity (RVTY) have higher forward dividend yields; Qiagen NV (QGEN) has the highest at 0.70%.
Is Adaptive Biotechnologies bigger than its competitors?
No. Adaptive Biotechnologies is 7th by market cap among the 13 companies on this page; the largest is Revvity (RVTY) at $17.24B.
ADPT pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts